Skip to main content

Table 2 Distribution of cases/deaths and sub-hazard ratios from competing risk analysis for each Cambridge Prognostic Group (CPG) category in the PCBaSe cohort (n = 72,337)

From: The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

CPG Number of men Deaths from prostate cancer Deaths from other causes Sub-hazard ratio (95% confidence interval) p value
1 25,303 482 3740 Reference NA
2 14,796 628 2912 2.30 (2.04–2.59) < 0.0001
3 7354 589 1532 4.70 (4.17–5.30) < 0.0001
4 13,506 1831 4011 7.42 (6.71–8.19) < 0.0001
5 11,378 3632 3726 20.52 (18.66–22.55) < 0.0001
Total 72,337 7162 15,921 _ _